A new class of drugs has become a phenomenon. GLP-1 receptor agonists, originally developed to treat type 2 diabetes, are now ...

(Reuters) -Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for ...

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...